Evaluation of a Selection of Lipid Profile and Kidney Function in Hypertensive Patients in Ramadi City, Western Iraq.

Read full text
Authors: Othman Mueen Mohammed, Haitham L. Abdulhadi
Cited by: 0

Abstract

The most common modifiable cardiovascular disease (CVD) risk element is hypertension, and CVD has a wide variety of conditions that include coronary artery disease, heart failure, cerebrovascular accidents, myocardial infarction, atrial fibrillation and peripheral arterial disease, among chronic kidney disease or CKD and cognitive impairment. Hypertension is the leading cause of death and disability worldwide. This cross-sectional research carried out in Ramadi, Iraq, assessed 50 cases of hypertension and 25 healthy individuals to determine the demographic trends, biochemical indicators, and cardiovascular risk factors. The prevalence of hypertension was diagnosed higher in women (68%) than in men (32%), and most common in the age category of 50 60 (56%), as compared to the regional trends of ageing. There was a high hereditary connection whereby 68 per cent of the patients claimed a family history of hypertension. Blood pressure measures showed that systolic pressure (16.72 ± 1.70 mmHg vs. 11.50± 0.65 mmHg) and diastolic pressure (9.89± 1.15 mmHg vs. 7.68± 0.61 mmHg) highly increased in the patients compared with experiences of controls (P < 0.0001). Biochemical studies have revealed an increased amount of uric acid in hypertensive patients (5.28 ± 1.35 mg/dL vs. 3.94 ± 0.52 mg/dL) but not of urea. The results highlight how genetic, metabolic, and lifestyle influencing factors are interconnected in causing hypertension in western Iraq and the importance of monitoring uric acid levels, controlling lipids, and the need to have targeted community health promotion programs to aid in reducing cardiovascular risks.

Fields of Study & Subjects

Sodium Intake and Health Gout Hyperuricemia Uric Acid Medical Case Reports and Studies

Publication details

Journal / source
Mağallaẗ al-tarbiyaẗ wa-al-ʻilm
Volume
35
Issue
1
Pages
65–74
Publication date
1 January 2026
Language
EN